After completing her MSc. in Organic Chemistry with Honours from the University of Milan, Silvia moved to Cambridge in 2011 where she obtained a PhD degree in Chemistry from the University of Cambridge with an emphasis on peptides self-assembly and supramolecular chemistry. In 2015, Silvia joined MedImmune as postdoctoral fellow, where she investigated supramolecular formulation of Antibody-Drug Conjugates. She then joined the Pharmaceutical Sciences department within AstraZeneca in 2017; in this position, she has been working with a broad range of new modalities and different therapeutic areas, with a focus on nanomedicines and long-acting peptide formulations.